L256-0271 Screening compound: N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide

L256-0271 Screening compound: N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide
L256-0271 Screening compound: N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L256-0271
N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L256-0271

Molecular Formula

C22H26N2O3 (C22 H26 N2 O3)

Compound Name

N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide

IUPAC name

N-[2-(1-benzoylpiperidin-4-yl)ethyl]-3-methoxybenzamide

SMILES

COc1cccc(C(NCCC(CC2)CCN2C(c2ccccc2)=O)=O)c1

InChI

InChI=1S/C22H26N2O3/c1-27-20-9-5-8-19(16-20)21(25)23-13-10-17-11-14-24(15-12-17)22(26)18-6-3-2-4-7-18/h2-9,16-17H,10-15H2,1H3,(H,23,25)

InChI Key

YVAXWQOFNSLTKC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15121099

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

366.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.913

Distribution Coefficient, logD

2.913

Water Solubility, LogSw

-3.49

Polar Surface Area

48.685

Acid Dissociation Constant (pKa)

13.49

Base Dissociation Constant (pKb)

-1.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

L256-0271 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L256-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L256-0271?
Check Price and Availability of L256-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L256-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L256-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L256-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L256-0271 available by request